Great Timing!

This acquisition of a company with cardiovascular obstruction products in the pipeline is an excellent buy for Pfizer.

May be an image of one or more people and text that says "SE djcalligraphy BLUE @DJcalligraphy BREAKING: Pfizer to acquire Arena Pharmaceuticals, a company that specializes in treatments for cardiovascular issues and autoimmune disorders BUSINESS BINOVATION Pfizer to buy Arena Pharmaceuticals in $6.7 billion deal By MIKE FREEMAN/THE SAN DIEGO UNION-TRIBUNE/TNS Published: DECEMBER 15, 2021 10:03"
May be an image of text that says "pfizer In addition, Arena's pipeline includes two development-stage cardiovascular assets, temanogrel and AP0418. remanogrel is currently in Phase 2 for the treatment of microvascular obstruction and Raynaud's phenomenon secondary to systemic sclerosis. APD418 is currently in Phase 2 for acute heart failure. "We're delighted to announce Pfizer's proposed acquisition of Arena, recognizing Arena's potentially best in class S1P molecule and our contribution to addressing unmet needs in immune-mediated inflammatory diseases," said Amit D. Munshi, President and Chief Executive Officer of Arena. "Pfizer's"
Loading spinner
Would love your thoughts, please comment.x